The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Cancer Yield of Mammography, MR, and US in High-Risk Women: Prospective Multi-Institution Breast Cancer Screening Study
Open accessAbstract
PURPOSE: To prospectively determine cancer yield, callback and biopsy rates, and positive predictive value (PPV) of mammography, magnetic resonance (MR) imaging, and ultrasonography (US) in women at high risk for breast cancer. MATERIALS AND METHODS: The study was approved by the institutional review board and was HIPAA compliant, and informed consent was obtained. We conducted a prospective pilot study of screening mammography, MR, and US in asymptomatic women 25 years of age or older who were genetically at high risk, defined as BRCA1/BRCA2 carriers or with at least a 20% probability of carrying a BRCA1/BRCA2 mutation. All imaging modalities were performed within 90 days of each other. Data were analyzed by using exact confidence intervals (CIs) and the McNemar test. RESULTS: A total of 195 women were enrolled in this study over a 6-month period, and 171 completed all study examinations (mammography, US, and MR). Average age of the 171 participants was 46 years +/- 10.2 (standard deviation). Sixteen biopsies were performed and six cancers were detected, for an overall 3.5% cancer yield. MR enabled detection of all six cancers; mammography, two; and US, one. The diagnostic yields for each test were 3.5% for MR, 0.6% for US, and 1.2% for mammography. MR, US, and mammography findings prompted biopsy in 8.2%, 2.3%, and 2.3% of patients, respectively. None of the pairwise comparisons were statistically significant. The PPV of biopsies performed as a result of MR was 43%. CONCLUSION: Screening MR imaging had a higher biopsy rate but helped detect more cancers than either mammography or US. US had the highest false-negative rate compared with mammography and MR, enabling detection of only one in six cancers in high-risk women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kolb, T. M., Lichy, J., & Newhouse, J. H. (2002) · Radiology · doi:10.1148/radiol.2251011667 · Cited by 1,718
Kriege, M., Brekelmans, C. T. M., Boetes, C., Besnard, P. E., Zonderland, H. M., Obdeijn, I. M., Manoliu, R. A., Kok, T., Peterse, H., Tilanus-Linthorst, M. M. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031759 · Cited by 1,687
Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
Easton, D. F., Ford, D., & Bishop, D. T. (1995) · PubMed Central · Cited by 1,602
American Cancer Society Guidelines for the Early Detection of Cancer
Smith, R. A., Cokkinides, V., von Eschenbach, A. C., Levin, B., Cohen, C., Runowicz, C. D., Sener, S., Saslow, D., & Eyre, H. J. (2002) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.52.1.8 · Cited by 1,588
Risk-Reducing Salpingo-oophorectomy in Women with a BRCA1 or BRCA2 Mutation
Kauff, N. D., Satagopan, J. M., Robson, M. E., Scheuer, L., Hensley, M., Hudis, C. A., Ellis, N. A., Boyd, J., Borgen, P. I., Barakat, R. R., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020119 · Cited by 1,251
Rebbeck, T. R., Friebel, T., Lynch, H. T., Neuhausen, S. L., van ’t Veer, L., Garber, J. E., Evans, G. R., Narod, S. A., Isaacs, C., Matloff, E., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.188 · Cited by 1,171
Self-citationBreast Cancer after Prophylactic Bilateral Mastectomy in Women with a BRCA1 or BRCA2 Mutation
Meijers-Heijboer, H., van Geel, B., van Putten, W. L. J., Henzen-Logmans, S. C., Seynaeve, C., Menke-Pluymers, M. B. E., Bartels, C. C. M., Verhoog, L. C., van den Ouweland, A. M. W., Niermeijer, M. F., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107193450301 · Cited by 973 · cited 1×
“2) [0, 4] 0/171 (0)”
Efficacy of Bilateral Prophylactic Mastectomy in BRCA1 and BRCA2 Gene Mutation Carriers
Hartmann, L. C., Sellers, T. A., Schaid, D. J., Frank, T. S., Soderberg, C. L., Sitta, D. L., Frost, M. H., Grant, C. S., Donohue, J. H., Woods, J. E., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.21.1633 · Cited by 743
Breast Cancer Risk After Bilateral Prophylactic Oophorectomy in BRCA1 Mutation Carriers
Rebbeck, T. R., Levin, A. M., Eisen, A., Snyder, C., Watson, P., Cannon-Albright, L., Isaacs, C., Olopade, O., Garber, J. E., Godwin, A. K., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.17.1475 · Cited by 672
Self-citationNarod, S. A., Brunet, J.-S., Ghadirian, P., Robson, M., Heimdal, K., Neuhausen, S. L., Stoppa-Lyonnet, D., Lerman, C., Pasini, B., de los Rios, P., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03258-x · Cited by 543
Kuhl, C. K., Schmutzler, R. K., Leutner, C. C., Kempe, A., Wardelmann, E., Hocke, A., Maringa, M., Pfeifer, U., Krebs, D., & Schild, H. H. (2000) · Radiology · doi:10.1148/radiology.215.1.r00ap01267 · Cited by 538
Magnetic Resonance Imaging of the Breast Prior to Biopsy
Bluemke, D. A. (2004) · JAMA · doi:10.1001/jama.292.22.2735 · Cited by 513
Self-citationBerry, D. A., Iversen, E. S., Gudbjartsson, D. F., Hiller, E. H., Garber, J. E., Peshkin, B. N., Lerman, C., Watson, P., Lynch, H. T., Hilsenbeck, S. G., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.05.121 · Cited by 505
Kolb, T. M., Lichy, J., & Newhouse, J. H. (1998) · Radiology · doi:10.1148/radiology.207.1.9530316 · Cited by 472
Screening women at high risk for breast cancer with mammography and magnetic resonance imaging
Lehman, C. D., Blume, J. D., Weatherall, P., Thickman, D., Hylton, N., Warner, E., Pisano, E., Schnitt, S. J., Gatsonis, C., Schnall, M., et al. (2005) · Cancer · doi:10.1002/cncr.20971 · Cited by 401
Self-citationMRI of Occult Breast Carcinoma in a High-Risk Population
Morris, E. A., Liberman, L., Ballon, D. J., Robson, M., Abramson, A. F., Heerdt, A., & Dershaw, D. D. (2003) · American Journal of Roentgenology · doi:10.2214/ajr.181.3.1810619 · Cited by 356
Brekelmans, C. T. M., Seynaeve, C., Bartels, C. C. M., Tilanus-Linthorst, M. M. A., Meijers-Heijboer, E. J., Crepin, C. M. G., van Geel, A. N., Menke, M., Verhoog, L. C., van den Ouweland, A., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.924 · Cited by 307
Breast and ovarian cancer incidence in BRCA1-mutation carriers
Easton, D., Ford, D., Bishop, D., Haites, N., Milner, B., Allan, L., Ponder, B., Peto, J., Smith, S., Ford, D., et al. (1995) · UCL Discovery (University College London) · Cited by 301
American Cancer Society Guidelines for the Early Detection of Cancer, 2004
Smith, R. A., Cokkinides, V., & Eyre, H. J. (2004) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.54.1.41 · Cited by 263
Incidental findings on sonography of the breast: clinical significance and diagnostic workup.
Buchberger, W., DeKoekkoek-Doll, P., Springer, P., Obrist, P., & Dünser, M. (1999) · American Journal of Roentgenology · doi:10.2214/ajr.173.4.10511149 · Cited by 230
First experiences in screening women at high risk for breast cancer with MR imaging
Tilanus-Linthorst, M. M. A., Obdeijn, I. M. M., Bartels, K. C. M., de Koning, H. J., & Oudkerk, M. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1006480106487 · Cited by 216
Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers
Rebbeck, T. R. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00269-1 · Cited by 95
The Cancer Genetics Network: Recruitment Results and Pilot Studies
Anton‐Culver, H., Ziogas, A., Bowen, D. J., Finkelstein, D. M., Griffin, C. A., Hanson, J. W., Isaacs, C. J., Kasten-Sportès, C., Mineau, G. P., Nadkarni, P. M., et al. (2003) · Public Health Genomics · doi:10.1159/000078165 · Cited by 60
Self-citationIntensive radiologic surveillance: a focus on the psychological issues
Warner, E. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh657 · Cited by 26
Cited by
Berg, W. A. (2008) · JAMA · doi:10.1001/jama.299.18.2151 · Cited by 1,526
Magnetic resonance imaging of the breast: Recommendations from the EUSOMA working group
Sardanelli, F., Boetes, C., Borisch, B., Decker, T., Federico, M., Gilbert, F. J., Helbich, T., Heywang-Köbrunner, S. H., Kaiser, W. A., Kerin, M. J., et al. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.02.015 · Cited by 992
Fass, L. (2008) · Molecular Oncology · doi:10.1016/j.molonc.2008.04.001 · Cited by 822
Lee, C. H., Dershaw, D. D., Kopans, D., Evans, P., Monsees, B., Monticciolo, D., Brenner, R. J., Bassett, L., Berg, W., Feig, S., et al. (2010) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2009.09.022 · Cited by 809
Metadata
- Authors
- Lehman, C. D., Isaacs, C., Schnall, M. D., Pisano, E. D., Ascher, S. M., Weatherall, P. T., Bluemke, D. A., Bowen, D. J., Marcom, P. K., Armstrong, D. K., Domchek, S. M., Tomlinson, G., Skates, S. J., & Gatsonis, C.
- Venue
- Radiology
- Published
- 2007-08
- Volume
- 244
- Issue
- 2
- Pages
- 381-388
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- OpenAlex
- W2133591380
- Cited by
- 396
- References
- 26
- FWCI
- 22.39
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.